Caprihans India Limited (BOM:509486)

India flag India · Delayed Price · Currency is INR
84.90
+1.81 (2.18%)
At close: Jan 23, 2026
-50.07%
Market Cap1.24B
Revenue (ttm)7.22B
Net Income (ttm)-546.60M
Shares Out14.62M
EPS (ttm)-38.53
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,352
Average Volume2,781
Open84.00
Previous Close83.09
Day's Range84.00 - 86.80
52-Week Range78.10 - 177.95
Beta0.31
RSI40.98
Earnings DateFeb 14, 2026

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, ... [Read more]

Industry Miscellaneous Plastics Products
Founded 1946
Employees 540
Stock Exchange Bombay Stock Exchange
Ticker Symbol 509486
Full Company Profile

Financial Performance

In 2024, Caprihans India's revenue was 7.40 billion, an increase of 6.36% compared to the previous year's 6.95 billion. Losses were -621.80 million, 20.5% more than in 2023.

Financial Statements